Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

JMP Securities Downgrades Pardes Biosciences to Market Perform

Author: Benzinga Newsdesk | July 18, 2023 05:22am
JMP Securities analyst Roy Buchanan downgrades Pardes Biosciences (NASDAQ:PRDS) from Market Outperform to Market Perform.

Posted In: PRDS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist